BREAST-PREDICT

Breast cancer is the second most common cancer affecting women in Ireland. Every year more than 3,000 women are diagnosed with the disease. Four in ten women diagnosed with breast cancer are aged between 50-64 (41%), but younger women are also affected, with 23% of diagnosis occurring in women under 50.

The number of breast cancer survivors are increasing, with 83% of those with a breast cancer diagnosis now living 5 years and beyond. But there's still much more we can do in our race to stop breast cancer. BREAST-PREDICT was the Irish Cancer Society‘s first Collaborative Cancer Research Centre.

About BREAST-PREDICT

BREAST-PREDICT was a country-wide collaboration between experts in the area of breast cancer research, funded by the Irish Cancer Society. This ‘Virtual Centre’ was launched in October 2013 and ran for a period of six years.

BREAST-PREDICT brought together a team of expert Irish researchers from six academic institutions across Ireland: UCD, TCD, RCSI, DCU, NUIG and UCC, as well as nationwide clinical trials group Cancer Trials Ireland. As a multi-disciplinary centre it united breast cancer experts with different skills to work towards a common goal.

The centre collected information and tumour samples from nearly every breast cancer patient in the country, with their consent. Using these valuable resources, researchers improved understanding of how this disease can spread and become resistant to treatment, and tested ways to combat this with new and better therapies. 


BREAST-PREDICT Downloadables

BREAST-PREDICT Achievements 

BREAST-PREDICT Achievements Inforgraphic

  • More than 3,400 patients joined nine BREAST-PREDICT-affiliated clinical and translational studies across 13 Irish hospitals. These patients consented to their samples being used for research studies. These trials were run through Cancer Trials Ireland. Patients and the public can access information on them through cancertrials.ie.

  • BREAST-PREDICT currently have 7 breast cancer diagnostic tests in development, and 17 novel drug therapies in testing, some reaching clinical trial phase.

  • BREAST-PREDICT was pivotal, together with other key entities, in the launch of a new Irish biobank of data that marks a major step forward in breast cancer research here. The National Breast Cancer Resource contains tissue, blood, DNA and RNA samples provided by breast cancer patients. The database currently holds information for more than 7,000 breast cancer cases. Cancer researchers in Ireland and elsewhere can request access to these specimens through nationalbreastcancerresource.ie, so as to generally advance knowledge in the breast cancer area.

  • Its 50-plus researchers have produced 134 BREAST-PREDICT scientific publications to date, comprising of 94 original and 40 review articles published in high-profile journals, several of which describe promising research advances likely to improve patient care.

  • The BREAST-PREDICT team worked to ensure that this important work will continue long after the Irish Cancer Society’s initial six-year investment. Already, more than €55 million in additional funding has been leveraged from other sources in academia, industry and state and EU grants, while its researchers and staff have been given training, education and career development support to the next generation of Irish cancer research leaders.

BREAST-PREDICT partners:

For more information see the BREAST-PREDICT website.

BREAST-PREDICT - Latest News

  • BREAST-PREDICT research brings new hope for hard to treat form of breast cancer. Read more.

  • Irish Cancer Society investment in BREAST-PREDICT research generates €55 million in additional funding for potentially life-saving work. Read more.

  • BREAST-PREDICT Day sees launch of new research on potential vitamin-D link to breast cancer. Read more.
     
  • BREAST-PREDICT scientists find new hope in fight against hard to treat form of breast cancer. Read more

  • More than 2,500 breast cancer patients participate in trials linked to Irish Cancer Society Research. Read more.

  • New Irish Cancer Society research offers hope for breast cancer patients resistant to treatment. Read more.

  • Irish Cancer Society researchers discover potential new way to treat aggressive type of breast cancer. Read more

  • Irish scientists find new hope in overcoming potentially deadly form of breast cancer. Read more.

  • 83% of women now survive breast cancer over five years compared to less than 50% in 1976. Read more.